跳至主要内容
临床试验/NCT03181165
NCT03181165已完成不适用

Impact of a Pharmacist-led Therapeutic Nutritional Intervention on Medications and Glucose Control in Type 2 Diabetes

University of British Columbia2 个研究点 分布在 1 个国家目标入组 188 人开始时间: 2017年7月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
188
试验地点
2
主要终点
Proportion of participants not on glucose-lowering medications

研究概览

简要总结

Type 2 diabetes represents a significant burden to both the individual and our healthcare system. Individuals with type 2 diabetes are typically prescribed one or more glucose-lowering medications, many of which have undesirable side effects (e.g., nausea, risk of cardiovascular complications, weight gain) and cost our healthcare system a lot of money. An alternative strategy to lower blood glucose is to consume a low-carbohydrate diet. However, adjusting medications after choosing to follow a low-carbohydrate diet can be difficult. Delivering a low-carbohydrate diet through pharmacists could circumvent this difficulty in medications adjustment because pharmacists are trained to adjust medications. In this study the investigators will determine whether type 2 diabetes patients can reduce medications and improve blood glucose by following a low-carbohydrate, low-calorie diet under the direction of a pharmacist.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Participants will know group assignments

入排标准

年龄范围
30 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 30 and 75, have type 2 diabetes mellitus diagnosed by a physician, are taking one or more glucose-lowering medications, have a BMI ≥30, have no contraindications to following low-carbohydrate, energy-restricted, high-protein diet, and can read and speak English.

排除标准

  • Exlcusion criteria are:
  • Recent (within the last 2 years) diagnosis of coronary heart disease, stroke, or a heart attack.
  • Unstable cardiovascular disorder.
  • History of liver disease.
  • History of kidney disease or impaired renal function.
  • Previously undergone bariatric surgery.
  • Multiple sclerosis or other diagnosed neurological disease.
  • Currently pregnant or lactating, or planning on becoming pregnant in the next 12 months.
  • Any form of cancer within the last 5 years.
  • Body mass index (BMI) of <
  • Dietary restrictions that do not allow you to follow a low-carbohydrate, energy-restricted, high-protein diet (e.g., vegan, food allergies).
  • Any sensitivities to the ingredients in the pre-packaged foods

结局指标

主要结局

Proportion of participants not on glucose-lowering medications

时间窗: 12 weeks

Number of individuals taking no medications divided by the total number of participants.

次要结局

  • Body mass(12 weeks)
  • Hemoglobin A1C(12 weeks)
  • Reduction in glucose-lowering medications(12 weeks)
  • Body mass index(12 weeks)
  • Waist circumference(12 weeks)
  • Body fat percentage(12 weeks)
  • Health related quality of life(12 weeks)
  • Blood lipid profile(12 weeks)
  • Fasting insulin(12 weeks)
  • Fasting C-peptide(12 weeks)
  • C-reactive protein(12 weeks)
  • Liver enzymes(12 weeks)
  • Fasting plasma glucose(12 weeks)
  • Systolic Blood Pressure(12 weeks)
  • Diastolic Blood Pressure(12 weeks)
  • Reduction in non-glucose lowering medications(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jonathan Little

Assistant Professor

University of British Columbia

研究点 (2)

Loading locations...

相似试验